Cargando…

A Case of Nivolumab-Induced Myositis

Nivolumab (Opdivo) is a monoclonal antibody classified as an immune modulator. A case is presented of nivolumab-induced myositis, an unlisted side effect.

Detalles Bibliográficos
Autores principales: Fox, Eric, Dabrow, Michael, Ochsner, Greg
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AlphaMed Press 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5153342/
https://www.ncbi.nlm.nih.gov/pubmed/27864576
http://dx.doi.org/10.1634/theoncologist.2016-0170
_version_ 1782474674247041024
author Fox, Eric
Dabrow, Michael
Ochsner, Greg
author_facet Fox, Eric
Dabrow, Michael
Ochsner, Greg
author_sort Fox, Eric
collection PubMed
description Nivolumab (Opdivo) is a monoclonal antibody classified as an immune modulator. A case is presented of nivolumab-induced myositis, an unlisted side effect.
format Online
Article
Text
id pubmed-5153342
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher AlphaMed Press
record_format MEDLINE/PubMed
spelling pubmed-51533422016-12-16 A Case of Nivolumab-Induced Myositis Fox, Eric Dabrow, Michael Ochsner, Greg Oncologist Letters to the Editor Nivolumab (Opdivo) is a monoclonal antibody classified as an immune modulator. A case is presented of nivolumab-induced myositis, an unlisted side effect. AlphaMed Press 2016-12 2016-11-18 /pmc/articles/PMC5153342/ /pubmed/27864576 http://dx.doi.org/10.1634/theoncologist.2016-0170 Text en ©AlphaMed Press
spellingShingle Letters to the Editor
Fox, Eric
Dabrow, Michael
Ochsner, Greg
A Case of Nivolumab-Induced Myositis
title A Case of Nivolumab-Induced Myositis
title_full A Case of Nivolumab-Induced Myositis
title_fullStr A Case of Nivolumab-Induced Myositis
title_full_unstemmed A Case of Nivolumab-Induced Myositis
title_short A Case of Nivolumab-Induced Myositis
title_sort case of nivolumab-induced myositis
topic Letters to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5153342/
https://www.ncbi.nlm.nih.gov/pubmed/27864576
http://dx.doi.org/10.1634/theoncologist.2016-0170
work_keys_str_mv AT foxeric acaseofnivolumabinducedmyositis
AT dabrowmichael acaseofnivolumabinducedmyositis
AT ochsnergreg acaseofnivolumabinducedmyositis
AT foxeric caseofnivolumabinducedmyositis
AT dabrowmichael caseofnivolumabinducedmyositis
AT ochsnergreg caseofnivolumabinducedmyositis